Avacopan is possibly associated with the improvement of ANCA-associated vasculitis activity without decreasing ANCA titres: a four-case series.
Rheumatology (Oxford)
; 62(11): e317-e318, 2023 11 02.
Article
in En
| MEDLINE
| ID: mdl-37086436
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Antineutrophil Cytoplasmic
/
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Year:
2023
Type:
Article